Skip to main content
Fig. 5 | Respiratory Research

Fig. 5

From: Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer

Fig. 5

Predictive performances of the Rad-score, C-reactive protein (CRP) level, and M stage (a) Kaplan–Meier analysis of the Rad-score. The patients were stratified into high- and low-risk groups based on the Rad-score (A, p < 0.0001, log-rank test). b Kaplan–Meier analysis of the CRP level. The patients were stratified into high- and low-risk groups based on the CRP level (B, p < 0.0001, log-rank test). c. Kaplan–Meier analysis of M stage. The patients were stratified into high- and low-risk groups on the basis of M stage (C, p = 0.03, log-rank test)

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us